Cargando…

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms

Detalles Bibliográficos
Autores principales:	Ramprasath, Tharmarajan, Natarajan, Nandakumar, Gopas, Jacob, Subbiah, Ramasamy, Rajendran, Peramaiyan, Vaiyapuri, Sakthivel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731149/ https://www.ncbi.nlm.nih.gov/pubmed/36506520 http://dx.doi.org/10.3389/fphar.2022.1088908

Ejemplares similares

Editorial: Metabolism Linking Immunity and Inflammatory Phenotypes in Cardiovascular Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

MiRNAs with Apoptosis Regulating Potential Are Differentially Expressed in Chronic Exercise-Induced Physiologically Hypertrophied Hearts
por: Ramasamy, Subbiah, et al.
Publicado: (2015)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice
por: Rajendran, Peramaiyan, et al.
Publicado: (2023)

Editorial: Crosstalk between epigenetics on the development of cancer and cardiovascular disease
por: Zhang, Donghong, et al.
Publicado: (2022)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases
por: Ramprasath, Tharmarajan, et al.
Publicado: (2021)

Editorial: Use of small peptides in the treatment of inflammatory diseases
por: Chemtob, Sylvain, et al.
Publicado: (2022)

Cancer Preventive Efficacy of Marine Carotenoid Fucoxanthin: Cell Cycle Arrest and Apoptosis
por: Rengarajan, Thamaraiselvan, et al.
Publicado: (2013)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Editorial: Metal-complexed molecules of natural and synthetic origin: Pharmacological advances and therapeutic applications
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
por: Pluta, Ryszard
Publicado: (2023)

β-hydroxybutyrate and its metabolic effects on age-associated pathology
por: Han, Young-Min, et al.
Publicado: (2020)

Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
por: Qin, Rui, et al.
Publicado: (2022)

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions
por: Stanke, Frauke, et al.
Publicado: (2023)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
por: Li, Ping, et al.
Publicado: (2017)

Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
por: Xiao, Guanlin, et al.
Publicado: (2023)

Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Editorial: Potential of Extracellular Matrix Molecules in Pharmaceutical Development
por: Zheng, Zhong, et al.
Publicado: (2021)

Chronic intake of 4-Methylimidazole induces Hyperinsulinemia and Hypoglycaemia via Pancreatic Beta Cell Hyperplasia and Glucose Dyshomeostasis
por: Rekha, Balakrishnan, et al.
Publicado: (2018)

Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
por: Exner, Agata A., et al.
Publicado: (2022)

Editorial: Anti-cancer bioactive molecules from microbial sources
por: Mishra, Bishwambhar, et al.
Publicado: (2023)

Editorial: Sex Differences in Inflammatory Diseases
por: Trabace, Luigia, et al.
Publicado: (2022)

Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide
por: Paidas, Michael J., et al.
Publicado: (2022)

Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020)

Editorial: Therapeutic implications of circadian rhythms
por: Yang, Guangrui, et al.
Publicado: (2015)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022)

Editorial: Prodrug design and therapeutic applications
por: Xiao, Qicai, et al.
Publicado: (2023)

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
por: Rosa, Arianna Carolina, et al.
Publicado: (2020)

Editorial: Natural Antimicrobial Peptides: Hope for New Antibiotic Lead Molecules
por: Uddin, Shaikh Jamal, et al.
Publicado: (2021)

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice
por: Purushothaman, Baskaran, et al.
Publicado: (2018)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Editorial: New Technologies in Cancer Diagnostics and Therapeutics
por: Li, Haichang, et al.
Publicado: (2021)

Editorial: Eye Pain: Etiology and Therapeutic Approaches
por: Rusciano, Dario, et al.
Publicado: (2022)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022)

Editorial: Novel modalities in cancer diagnostics and therapeutics
por: Zhao, Serena Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3agog6d3lqhgref5pir8glh8v